People living with CTEPH face significant symptoms that affect daily life, even when receiving treatment, a real-world U.S.

Findings reinforce brilaroxazine’s treatment effect on negative symptoms and other symptom domains in schizophrenia and support ...

(Alliance News) - GSK PLC on Monday said mepolizumab, sold under the brand name Nucala, has been approved in China for use in adults with chronic obstructive pulmonary disease. The London-based ...

Background The relationship of social determinants of health (SDOH), environmental exposures and medical history to lung function trajectories is underexplored. A better understanding of these ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2026. | In this tracker, Fierce Pharma is recording the ...

Patients with COPD who did not complete their 6MWT had higher rates of future exacerbations and mortality than those who completed the test. Early termination of the 6-minute walk test (6MWT) may be a ...

Introduction There is growing evidence to support the use of interventions beyond inhaled medications in COPD. Clinician attitudes and access to these therapies are crucial to informing COPD care ...

House GOP moderates on Wednesday privately huddled with a bipartisan group of senators to begin plotting the next steps on extending the Affordable Care Act’s enhanced subsidies. The meeting came ...

It’s a time of choosing for a band of vulnerable House Republicans who have long warned about the expiration of key Obamacare subsidies. Speaker Mike Johnson is barreling toward a Wednesday vote on a ...